Concepedia

Comparison of diagnostic accuracy of 111In-pentetreotide SPECT and 68Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours

Sofie Van Binnebeek, B Vanbilloen, Kristof Baete, Christelle Terwinghe, Michel Koole, Felix M. Mottaghy, Paul M. Clément, L. Mortelmans, Kris Bogaerts, Karin Haustermans,

European Radiology · 2015 · 98 citations · 17 references

DOI

Concepts

References

17

Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival

Dik J. Kwekkeboom, Wouter W. de Herder, Boen L.R. Kam et al. · Journal of Clinical Oncology · 2008 · 1.4K citations · Full text

, , +17

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

Jean Claude Reubi, Jean-Claude Schär, Beatrice Waser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 1.1K citations

, , +15

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

Michael Gabriel, Clemens Decristoforo, Dorota Kendler et al. · Journal of Nuclear Medicine · 2007 · 1K citations · Full text

, , +17

Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [<sup>90</sup>Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers

Anna Imhof, Philippe Brunner, Nicolas Marincek et al. · Journal of Clinical Oncology · 2011 · 621 citations

, , +17

Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data

Michael Hofmann, Helmut R. Maëcke, A. Börner et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 541 citations

, , +14